The effect of Monthly ibandronate iv injected on the low-responders to pre-existing oral BP treatment for the osteoporosis patients

Trial Profile

The effect of Monthly ibandronate iv injected on the low-responders to pre-existing oral BP treatment for the osteoporosis patients

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 15 Apr 2017

At a glance

  • Drugs Ibandronic acid (Primary)
  • Indications Osteoporosis
  • Focus Therapeutic Use
  • Acronyms MOVEMENT
  • Most Recent Events

    • 03 Apr 2017 Status changed from recruiting to active, no longer recruiting.
    • 30 Oct 2015 Status changed from not yet recruiting to recruiting, as reported by University Hospital Medical Information Network - Japan.
    • 10 Jun 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top